
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc. is projecting total revenues of $890 million for 2026, reflecting an anticipated 17% growth over preliminary 2025 figures, supported by strong surgeon adoption and established territory revenue growth. The company has demonstrated impressive operational metrics, with a year-over-year revenue increase of 25%, primarily driven by a 24% rise in surgical procedure volumes and a solid adjusted EBITDA of $26 million, exceeding prior expectations. Given the organization's positive trajectory in revenue growth and operational performance, along with improved margins and free cash flow prospects, there is a positive outlook for Alphatec Holdings’s stock moving forward.
Bears say
Alphatec Holdings, despite reporting total revenues slightly exceeding management's guidance and consensus estimates, faces significant headwinds including a projected 31% decline in revenue growth and lower-than-expected free cash flow, indicating potential challenges in financial performance. The company’s bear case assumptions highlight concerns with slower revenue growth in the U.S. and a weakening sequential growth rate in surgical services, which may adversely impact investor confidence. Additionally, risks such as poor sales execution, heightened competition in the spine market, and potential disruptions from ongoing pandemic-related factors further contribute to the pessimistic outlook for Alphatec's stock.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares